Bioequivalence studies for GCC submission [Design Issues]

posted by professionalr – India, 2025-01-31 00:00 (147 d 22:42 ago) – Posting: # 24353
Views: 2,121

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,686 registered users;
79 visitors (0 registered, 79 guests [including 11 identified bots]).
Forum time: 23:42 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5